Clinical Trial Update: Investigating the Effects of Lipid-therapy Intensification With Alirocumab on Endothelial Function, Carotid Arteries, Lipoprotein Particle Subfractions, Inflammation and Post-prandial Lipemia [Phase 4]

View source ↗

Summary

Phase 4 trial investigating alirocumab intensification effects on endothelial function, carotid arteries, lipoprotein subfractions, inflammation, and post-prand…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Cardiovascular Diseases
• Hypercholesterolemia

Drugs mentioned

• alirocumab (alirocumab)

Snippet

Sponsor: Medical University of Graz | Conditions: Atherosclerosis, Hypercholesterolemia | Phase 4 | Status: TERMINATED